● Recruiting

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

Condition: Diabetic Macular Edema · DME · Diabetic Macular Edema (DME) · Sponsor: EyePoint Pharmaceuticals, Inc.

PhasePhase 3

Planned participants240

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

This description comes directly from the study's public registry record.

Talk to the study team

Ramiro Ribeiro, MD, PhD · 833-393-7646 · rribeiro@eyepoint.bio

Always discuss trial participation with your own doctor first.

Locations (70)

California Retina Consultants	Bakersfield, California, United States	Recruiting
The Retina Partners	Encino, California, United States	Recruiting
Global Research Management, Inc.	Glendale, California, United States	Recruiting
Northern California Retina Vitreous Associates Medical Group INC.	Mountain View, California, United States	Recruiting
Retina Consultants of San Diego	Poway, California, United States	Recruiting
California Eye Specialists Medical Group, Inc.	Redlands, California, United States	Recruiting
Retinal Consultants Medical Group - Parkcenter Drive	Sacramento, California, United States	Recruiting
Retinal Consultants Medical Group	Sacramento, California, United States	Recruiting
Retina Consultants of Southern Colorado	Colorado Springs, Colorado, United States	Recruiting
Colorado Retina Associates	Lakewood, Colorado, United States	Recruiting
Advance Medical Research Group, Inc	Deerfield Beach, Florida, United States	Recruiting
Eye Associates of Pinellas	Pinellas Park, Florida, United States	Recruiting

+ 58 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07449936